In a paper published in Nature Cancer, investigators from Brigham and Women’s Hospital, in collaboration with international colleagues, present a new, quantitative technique that leverages DNA sequencing to make more sophisticated and accurate predictions about which primary melanomas are likely to recur and spread.
Primary melanoma patients with lower T-cell fraction are 2.5 times more likely to have cancer metastasize than patients with higher T-cell fraction.
